BPTQ is a typical intercalator of DNA. It acts by inducing dose-dependent inhibitory effect on the proliferation of cancer cells by arresting cells at S and G2/M phase and activating the mitochondria-mediated apoptosis pathway. References: Rohit Kumar H, Kumar CS, Kiran Kumar HN, Advi Rao GM. Inhibition of protein kinases by anticancer DNA intercalator, 4-butylaminopyrimido[4',5':4,5]thieno(2,3-b)quinoline. Acta Pharm Sin B. 2017 May;7(3):303-310. doi: 10.1016/j.apsb.2017.01.001. Epub 2017 Mar 7. PubMed PMID: 28540166; PubMed Central PMCID: PMC5430831.

纯度：≥98%

CAS：1802665-43-5